A man in his fifties often suffered from back pain, especially after drinking whiskey, which made his back more painful. He went to the orthopedic department, but could not find the cause. After two months of repeated consultations and treatment, After various examinations, it was finally discovered that it was lymphoma. When the diagnosis was made, it was already the third stage of lymphoma. Drinking whiskey worsens back pain, warning of lymphoma cancer! Zhang Mingzhi, senior attending physician at the Department of Hematology and Oncology at Mackay Memorial Hospital, said that symptoms of lymphoma include painless lymphadenopathy, fever, night sweats, weight loss, fatigue, etc. Some patients experience atypical symptoms such as itchy skin and bone aches, especially Patients with bone soreness often experience more severe back pain after drinking whiskey and other spirits. This is because whiskey and other spirits can cause tumor cells to secrete special cell hormones, resulting in this phenomenon. When patients experience the above symptoms, most of them will not think it is lymphoma at the first time, and it is easy for them to be misdiagnosed and delay treatment. There are also patients who have unexplained fevers. Other doctors thought it was a cold or infection and tried their best to give them antibiotics, but the symptoms still did not improve. After a checkup, they discovered that it was lymphoma. Doctors remind that if the fever persists for two weeks and the symptoms still do not improve, or if a lump in the neck appears but does not feel pain, it is best to seek medical treatment as soon as possible for further examination. The kissing disease is also related to lymphoma. Dr. Zhang Mingzhi explained that the medical community is still unclear about the real cause of lymphoma. It is speculated that it may be related to genetics, autoimmune diseases, and environmental factors. "Infectious mononucleosis" commonly known as the kissing disease is also Related to lymphoma, foreign studies have found that patients who have suffered from "infectious mononucleosis" have a higher risk of developing lymphoma in the next five to ten years than the average person. Treatment options for refractory lymphoma are increasing. Dr. Jim Lai, CEO of the Taiwan Cancer Foundation and Vice President of Research at Wanfang Hospital, said that lymphoma is divided into "Hodgkin's lymphoma" (HL) and "non-Hodgkin's lymphoma" ( There are two major categories of NHL (NHL). The symptoms of the two are similar, and pathological examination is required to confirm the diagnosis. According to the 102 Cancer Registration Annual Report, about 3,200 cases of malignant lymphoma are newly diagnosed in Taiwan every year. Most patients receive radiotherapy and chemotherapy, and most of them recover; however, For example, there are 200 new cases of Hodgkin's lymphoma every year. Most of the patients are between the ages of 15 and 34. According to statistics, about 20% of Hodgkin's lymphoma patients still have a half chance of receiving treatment and autologous stem cell transplantation. Relapse, these patients with "relapsed and refractory lymphoma" did not have many drug options in the past. Currently, CD30 "antibody-drug complex" drugs are available. This drug has been included in the list since October 1 this year (2016). With health insurance benefits, patients not only have a better chance of survival, but their financial burden is also greatly reduced. However, Dr. Zhang Mingzhi also reminded that only adult patients can use CD30 "antibody-drug complex" drugs. Some patients may experience side effects such as peripheral neuritis after taking the drug. Taiwan Cancer Foundation launches related health education website In addition, the Taiwan Cancer Foundation launched the "exclusive health education website for patients with relapsed and refractory lymphoma care08i". Dr. Lai Jiming said, "Knowledge is power!" In addition to relapsed and refractory lymphoma, the website has Treatment information will be introduced, and doctors with treatment experience will also be interviewed, hoping to bring survival fighting spirit and energy to patients with relapsed and refractory lymphoma and their families, and increase the patient's chance of survival.